Search research articles
Contact Us
Filters
Showing results (171-180 of 199) with videos related to
Page
of 20
Sort By:
Bone Marrow Transplantation
|
October 16, 2002
Collection of peripheral blood stem cells in newly diagnosed myeloma patients without any prior cytoreductive therapy: the first step towards an 'operational cure'?
R Powles, B Sirohi, S Kulkarni, et al.
Medical Oncology (Northwood, London, England)
|
January 10, 2002
The implication of compromised renal function at presentation in myeloma: similar outcome in patients who receive high-dose therapy: a single-center study of 251 previously untreated patients
B Sirohi, R Powles, J Mehta, et al.
Bone Marrow Transplantation
|
October 6, 1997
Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment
R Powles, N Raje, S Milan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1991
Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: the British autograft group experience
R Chopra, A H Goldstone, A K McMillan, et al.
Bone Marrow Transplantation
|
March 14, 2000
Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation
S Singhal, R Powles, S Kulkarni, et al.
British Journal of Haematology
|
April 1, 1997
A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C-VAMP) as induction treatment followed by autografting in previously untreated myeloma
N Raje, R Powles, S Kulkarni, et al.
Bone Marrow Transplantation
|
October 6, 2000
A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold?
S Singhal, R Powles, J Treleaven, et al.
Lancet (London, England)
|
April 19, 2000
Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial
R Powles, J Mehta, S Kulkarni, et al.
British Journal of Haematology
|
August 8, 1998
A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up results
D Cunningham, R Powles, J Malpas, et al.
European Journal of Cancer
|
June 1, 1977
Encephalopathy following bone marrow transplantation
K Atkinson, H Clink, S Lawler, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 199) with videos related to
Sort By:
Page
of 20
Bone Marrow Transplantation
|
October 16, 2002
Collection of peripheral blood stem cells in newly diagnosed myeloma patients without any prior cytoreductive therapy: the first step towards an 'operational cure'?
R Powles, B Sirohi, S Kulkarni, et al.
Medical Oncology (Northwood, London, England)
|
January 10, 2002
The implication of compromised renal function at presentation in myeloma: similar outcome in patients who receive high-dose therapy: a single-center study of 251 previously untreated patients
B Sirohi, R Powles, J Mehta, et al.
Bone Marrow Transplantation
|
October 6, 1997
Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment
R Powles, N Raje, S Milan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1991
Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: the British autograft group experience
R Chopra, A H Goldstone, A K McMillan, et al.
Bone Marrow Transplantation
|
March 14, 2000
Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation
S Singhal, R Powles, S Kulkarni, et al.
British Journal of Haematology
|
April 1, 1997
A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C-VAMP) as induction treatment followed by autografting in previously untreated myeloma
N Raje, R Powles, S Kulkarni, et al.
Bone Marrow Transplantation
|
October 6, 2000
A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold?
S Singhal, R Powles, J Treleaven, et al.
Lancet (London, England)
|
April 19, 2000
Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial
R Powles, J Mehta, S Kulkarni, et al.
British Journal of Haematology
|
August 8, 1998
A randomized trial of maintenance interferon following high-dose chemotherapy in multiple myeloma: long-term follow-up results
D Cunningham, R Powles, J Malpas, et al.
European Journal of Cancer
|
June 1, 1977
Encephalopathy following bone marrow transplantation
K Atkinson, H Clink, S Lawler, et al.
Page
of 20